Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4694577 | 0.86 | MEN1 (0.35) | MEN1KMT2ARXFP1ERBB2SMN1; SMN2 | |
| SCHEMBL4696863 | 0.83 | MEN1 (0.37) | MEN1KMT2APOLBRXFP1ERBB2 | |
| SCHEMBL4697597 | 0.74 | GAA (0.44) | MEN1KMT2APOLBRXFP1EPHX2 | |
| SCHEMBL4693654 | 0.71 | CYP1A2 (0.47) | BDKRB1MEN1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL6413365 | 0.71 | TSHR (0.40) | MEN1KMT2APOLBRXFP1SMN1; SMN2 | |
| SCHEMBL6416941 | 0.70 | SMN1; SMN2 (0.37) | MEN1KMT2APOLBSMN1; SMN2GAA | |
| SCHEMBL4696776 | 0.67 | ALDH1A1 (0.53) | MEN1KMT2APOLBSMN1; SMN2GAA | |
| SCHEMBL4696088 | 0.62 | ADRA1D (0.58) | SMN1; SMN2GAA | |
| SCHEMBL4695768 | 0.60 | CYP1A2 (0.47) | SMN1; SMN2GAALMNA | |
| SCHEMBL6417121 | 0.60 | ESR1 (0.52) | SMN1; SMN2GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109542-A4 | NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2008-03-26 | — | — | EP | disclosed |
| EP-1109542-A1 | NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2001-06-27 | — | — | EP | disclosed |
| WO-2000012075-A1 | NITROSATED AND NITROSYLATED ALPHA-ADRENERGIC RECEPTOR ANTAGONISTS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2000-03-09 | — | — | WO | disclosed |